HOTH

Hoth Therapeutics Stock Price

1.3707
-0.0193 (-1.39%)
Upgrade to Real-Time
Regular Market
1.3707

Low
1.2663

52 Week Range

High
4.95

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Hoth Therapeutics Inc HOTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0193 -1.39% 1.3707 13:36:42
Open Price Low Price High Price Close Price Prev Close
1.38 1.33 1.38 1.39
Bid Price Ask Price Spread News
1.37 1.38 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
335 164,090 $ 1.37 $ 224,767 - 1.2663 - 4.95
Last Trade Time Type Quantity Stock Price Currency
13:36:42 200 $ 1.3707 USD

Period:

Draw Mode:

Hoth Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 32.72M 23.87M 22.97M $ - $ - -0.58 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 3.90%

more financials information »

Hoth Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HOTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.371.461.331.39257,0410.00070.05%
1 Month1.611.691.331.50376,311-0.2393-14.86%
3 Months1.64632.201.26631.581,258,210-0.2756-16.74%
6 Months2.333.501.26632.132,823,397-0.9593-41.17%
1 Year2.954.951.26632.222,166,025-1.58-53.54%
3 Years10.2813.881.26632.34990,229-8.91-86.67%
5 Years10.2813.881.26632.34990,229-8.91-86.67%

Hoth Therapeutics Description

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.


Your Recent History
NASDAQ
HOTH
Hoth Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.